NCT03071003View on ClinicalTrials.gov

A Study of SENS 401 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 21, 2016

Primary Completion Date

March 21, 2017

Study Completion Date

October 16, 2017

Conditions
Inner Ear Disease
Interventions
DRUG

SENS-401

Oral Administration

DRUG

Placebo

Oral Administration

Trial Locations (1)

CF48 4DR

Simbec Research, Merthyr Tydfil

Sponsors

Collaborators (1)

Sensorion
All Listed Sponsors
collaborator

Sensorion

INDUSTRY

lead

Simbec Research

INDUSTRY

NCT03071003 - A Study of SENS 401 in Healthy Subjects | Biotech Hunter | Biotech Hunter